AdvaMed COVID Testing Supply Registry – Weekly Report
This report outlines a key data-driven summary of the U.S. COVID testing supply.
Diagnostics
Learn more about our Diagnostics work.
Easing Disparities for Patients via Smart Technology, Equally Smart Policies
CEO and surgeon Dr. Lishan Aklog speaks about the tremendous value of medical technology, the sharp disparities patients face, and the importance of policymaking to ease those disparities.
AdvaMed Submits Comments on Genetic Testing in Oncology LCD
AdvaMed submitted a letter to Medicare Administrative Contractors, Novitas and First Coast Service Options, regarding proposed LCDs on Genetic Testing in Oncology.
AdvaMedDx COVID Testing Supply Retrospective Report
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
The VALID Act Sponsor Prepared Summaries And Fact Sheets
Read a section-by-section breakdown of the Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021.
AdvaMed Welcomes the UK Government’s Commitment to Address Elective Recovery and Access to Care
The Advanced Medical Technology Association (AdvaMed), working in the United Kingdom with the Medical Technology Group (MTG) and the Association of British HealthTech Industries (ABHI), commends the recent announcement by the UK Government of aggressive polices to address…
AdvaMed Statement on White House Request for Information on COVID-19 Test Manufacturing
Today, AdvaMed President and CEO Scott Whitaker applauded the White House’s Request for Information on policies to sustain diagnostic test manufacturing for COVID-19.
AdvaMed, Semiconductor Industry Association Convene Roundtable on Supply Chain Issues
Last week, AdvaMed President and CEO Scott Whitaker and Semiconductor Industry Association (SIA) President and CEO John Neuffer hosted a joint roundtable discussion that included dozens of industry leaders and…
AdvaMedDx 2022 Priorities
AdvaMed and AdvaMedDx have prioritized supporting Medtech’s mobilization to the pandemic to protect patients and public health.